Fidelity Investments
CLOV icon

Fidelity Investments’s Clover Health Investments CLOV Stock Holding History

Fidelity Investments’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.5K Buy
14,796
+416
+3% +$1.41K ﹤0.01% 4097
2026
Q1 		$25.3K Sell
14,380
-8,041
-36% -$17.4K ﹤0.01% 4422
2025
Q4 		$52.7K Buy
22,421
+8,815
+65% +$24.1K ﹤0.01% 4084
2025
Q3 		$41.6K Buy
13,606
+5,442
+67% +$15.5K ﹤0.01% 4063
2025
Q2 		$22.8K Buy
8,164
+685
+9% +$2.25K ﹤0.01% 4242
2025
Q1 		$26.9K Buy
7,479
+2,732
+58% +$11K ﹤0.01% 4110
2024
Q4 		$15K Buy
4,747
+891
+23% +$3.18K ﹤0.01% 4305
2024
Q3 		$10.9K Sell
3,856
-951
-20% -$2.18K ﹤0.01% 4403
2024
Q2 		$5.91K Sell
4,807
-2,464
-34% -$2.21K ﹤0.01% 4498
2024
Q1 		$5.77K Sell
7,271
-29,569
-80% -$26.9K ﹤0.01% 4462
2023
Q4 		$35.1K Buy
36,840
+23,729
+181% +$23.3K ﹤0.01% 3687
2023
Q3 		$14.2K Buy
13,111
+3,237
+33% +$3.85K ﹤0.01% 3975
2023
Q2 		$8.86K Sell
9,874
-7,134
-42% -$6.33K ﹤0.01% 4194
2023
Q1 		$14.4K Buy
17,008
+9,816
+136% +$10.7K ﹤0.01% 3984
2022
Q4 		$6.68K Sell
7,192
-277,557
-97% -$370K ﹤0.01% 4157
2022
Q3 		$484K Sell
284,749
-140,889
-33% -$369K ﹤0.01% 2790
2022
Q2 		$911K Buy
425,638
+424,867
+55,106% +$1.13M ﹤0.01% 2697
2022
Q1 		$3K Buy
771
+1
+0.1% +$3 ﹤0.01% 4553
2021
Q4 		$3K Sell
770
-811
-51% -$4.97K ﹤0.01% 3910
2021
Q3 		$11K Sell
1,581
-4,258,673
-100% -$36.4M ﹤0.01% 3583
2021
Q2 		$56.2M Buy
4,260,254
+675
+0% +$6.63K ﹤0.01% 1377
2021
Q1 		$29.3M Buy
+4,259,579
New +$48.1M ﹤0.01% 1626

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments's CLOV Position: Q2 2026 in Review

Fidelity Investments increased its Clover Health Investments (CLOV) stake by 2.9% in Q2 2026, buying an estimated $1.41K and bringing the position to 14,796 shares worth $77.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4097.

Fidelity Investments first reported a position in CLOV in Q1 2021 and has held it in 22 quarters since. The position peaked at $56.2M in Q2 2021. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Fidelity Investments held 14,796 shares of Clover Health Investments worth $77.5K as of Q2 2026.
  • Fidelity Investments bought 416 Clover Health Investments shares in Q2 2026, an estimated $1.41K.
  • Clover Health Investments made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4097 holding.
  • Fidelity Investments first reported a position in Clover Health Investments in Q1 2021 and has held it in 22 quarters since.
  • Fidelity Investments's Clover Health Investments position peaked at $56.2M in Q2 2021.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.